Department of Psychology, Binghamton University, Binghamton, New York, USA.
Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, USA.
Addict Biol. 2022 May;27(3):e13162. doi: 10.1111/adb.13162.
Cocaine self-administration is a complexly determined trait, with a substantial proportion of individual differences being determined by genetic variation. However, the relevant genetic variants that drive heritable differences in cocaine use remain undiscovered. Cocaine intravenous self-administration (IVSA) procedures in laboratory animals provide opportunities to prospectively investigate neurogenetic influences on the acquisition of voluntary cocaine use. Here, we provide information on cocaine (or saline-as a control) IVSA in 84 members of the hybrid mouse diversity panel (HMDP), an array of genetically distinct classical or recombinant inbred strains. We found cocaine IVSA to be substantially heritable in this population, with strain-level intake ranging for near 0 to >25 mg/kg/session. Though saline IVSA was also found to be heritable, a modest genetic correlation between cocaine and saline IVSA indicates that operant responding for the cocaine reinforcer was influenced, at least in part, by unique genetic variants. Genome-wide association studies (GWAS) of infusions earned in cocaine and saline groups revealed significant quantitative trait loci (QTL) on Chromosomes 3 and 14 for cocaine, but not saline, IVSA. Positional candidates were further prioritized through use of bulk RNA sequencing data that revealed genes with cis-eQTL and genetic correlation to number of infusions. Additionally, these data identify reference strains with extreme cocaine IVSA phenotypes, revealing them as polygenic models of risk and resilience to cocaine reinforcement. This work is part of an ongoing effort to characterize genetic variation that moderates cocaine IVSA that may, in turn, provide a more comprehensive understanding of cocaine risk genetics and neurobiology.
可卡因自我给药是一种复杂决定的特征,个体差异的很大一部分是由遗传变异决定的。然而,导致可卡因使用可遗传性差异的相关遗传变异仍未被发现。实验室动物的可卡因静脉自我给药(IVSA)程序为前瞻性研究神经遗传对自愿使用可卡因的获得的影响提供了机会。在这里,我们提供了 84 名杂交鼠多样性面板(HMDP)成员的可卡因(或盐水对照)IVSA 信息,这是一组遗传上明显不同的经典或重组近交系。我们发现,在该人群中,可卡因 IVSA 具有显著的遗传性,剂量水平摄入范围接近 0 至>25mg/kg/次。虽然盐水 IVSA 也被发现具有遗传性,但可卡因和盐水 IVSA 之间适度的遗传相关性表明,可卡因强化物的操作性反应至少部分受到独特遗传变异的影响。可卡因和盐水组输注量的全基因组关联研究(GWAS)显示,可卡因 IVSA 在第 3 和第 14 染色体上有显著的数量性状基因座(QTL),但盐水 IVSA 没有。通过使用包含顺式-eQTL 和与输注次数遗传相关性的基因的批量 RNA 测序数据,进一步对位置候选基因进行了优先级排序。此外,这些数据确定了具有极端可卡因 IVSA 表型的参考品系,揭示了它们作为可卡因强化风险和恢复力的多基因模型。这项工作是正在进行的特征描述可卡因 IVSA 调节遗传变异的一部分,这可能反过来提供对可卡因风险遗传学和神经生物学的更全面理解。